Home / Crime and Justice / Surprise Plea May Upend NYC Murder Trial
Surprise Plea May Upend NYC Murder Trial
13 Aug
Summary
- Accused CEO assassin may plead guilty to federal charges.
- A plea deal could delay the New York City murder trial.
- Jury selection for the state trial was scheduled for September 8.
The suspect accused in the assassination of the UnitedHealthcare CEO is expected to enter a guilty plea for federal charges. This development, occurring at a surprise pretrial conference, could significantly disrupt the proceedings for his New York City murder trial.
Jury selection for the state-level murder trial was scheduled to commence on September 8. However, the potential plea deal in the federal case may cause a postponement. The suspect had previously entered pleas of not guilty to all charges leveled against him in both the state and federal cases.
Defense attorneys have managed to have the most serious charges dismissed in both the state and federal proceedings. This means the suspect would no longer face the possibility of capital punishment in a federal trial or life imprisonment without parole in the New York state trial if convicted.
